Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Schoemaker Kathleen K
Relationship:   10% Owner
City:   Princeton
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   24    
Direct Shares   8,715,548    

Indirect Shares

   3,038,103      
Direct Value   $230,129,814    

Indirect Value

   $11,501,958      
Total Shares   11,753,651      
Total Value   $241,631,772      


Volcano Corp $0 Cadence Pharmaceuticals Inc $0 Orexigen Therapeutics, Inc. $48 Alimera Sciences Inc $1,095,234 Clovis Oncology, Inc. $661 Glaukos Corp $229,033,872 Volcano Corp $0 Cadence Pharmaceuticals Inc $0 Orexigen Therapeutics, Inc. $48 Alimera Sciences Inc $1,095,234 Clovis Oncology, Inc. $661 Glaukos Corp $229,033,872
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Senomyx Inc SNMX 10% Owner 0 2004-06-25 19,603    Premium*  
            Nuvasive Inc NUVA 10% Owner 0 2004-05-18 31,204    Premium*  
            Santarus Inc SNTS 10% Owner 2004-04-06 0 2004-04-06 64,471    Premium*  
            Somaxon Pharmaceuticals, Inc. SOMX 10% Owner 0 2006-12-21 19,379    Premium*  
            Vanda Pharmaceuticals Inc. VNDA 10% Owner 2006-04-18 0 2006-12-12 21,068    Premium*  
            Northstar Neuroscience Inc NSTR 10% Owner 0 2006-05-10 37,586    Premium*  
            Paratek Pharmaceuticals Inc PRTK 10% Owner 0 2009-01-30 67,875    Premium*  
            Volcano Corp VOLC 10% Owner 2008-04-24 29,887 2008-07-16 62,513    Premium*  
            Cadence Pharmaceuticals Inc CADX 10% Owner 2014-02-12 2,972,678 2014-03-19 0    Premium*  
            Orexigen Therapeutics, Inc. OREX 10% Owner 2007-11-27 9,058 2011-12-22 50,643    Premium*  
            Alimera Sciences Inc ALIM 10% Owner 2014-01-16 3,590,931 2011-06-02 40,790    Premium*  
            Achillion Pharmaceuticals Inc ACHN 10% Owner 0 2013-01-18 244,057    Premium*  
            Zogenix, Inc. ZGNX 10% Owner 2010-11-29 0 2011-09-16 169,251    Premium*  
            Clovis Oncology, Inc. CLVS 10% Owner 2013-06-04 44,034 2011-11-21 51,013    Premium*  
            Durata Therapeutics, Inc. DRTX 10% Owner 0 2012-07-24 22,306    Premium*  
            Esperion Therapeutics, Inc. ESPR 10% Owner 0 2013-07-01 35,253    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2013-07-15 0 2013-07-15 1,920,730    Premium*  
            Tobira Therapeutics Inc TBRA 10% Owner 0 2013-08-27 32,091    Premium*  
            Evoke Pharma Inc EVOK 10% Owner 0 2013-09-30 24,256    Premium*  
            Veracyte, Inc. VCYT 10% Owner 2013-11-04 0 2013-11-04 22,730    Premium*  
            Tandem Diabetes Care Inc TNDM 10% Owner 2013-11-19 0 2013-11-19 54,390    Premium*  
            Dicerna Pharmaceuticals Inc DRNA 10% Owner 2014-02-04 0 2014-02-04 13,004    Premium*  
            Achaogen Inc AKAO 10% Owner 2014-03-17 0 2014-03-17 33,890    Premium*  
            Glaukos Corp GKOS 10% Owner 2015-06-30 2,068,960 2015-06-30 0    Premium*  
* Premium Members only  

Records found :    282         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 12
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-01-31 4 AS $4.71 $269,247 D/D (57,165) 7,865,575 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-01-31 4 AS $4.71 $2,887 D/D (613) 84,291 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-02-01 4 AS $4.85 $1,562 D/D (322) 83,969 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-02-01 4 AS $4.85 $146,150 D/D (30,134) 7,835,441 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-02-01 4 AS $4.85 $795 D/D (164) 43,354 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-02-01 4 AS $4.85 $47,380 D/D (9,769) 2,540,520 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-02-13 4 AS $5.00 $955 D/D (191) 83,778 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-02-13 4 AS $5.00 $88,850 D/D (17,770) 7,817,671 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-02-13 4 AS $5.00 $490 D/D (98) 43,256 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-02-13 4 AS $5.00 $28,815 D/D (5,763) 2,534,757 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-02-14 4 AS $5.01 $45,591 D/D (9,100) 7,808,571 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-02-14 4 AS $5.01 $256 D/D (51) 43,205 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-02-14 4 AS $5.01 $14,785 D/D (2,951) 2,531,806 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-02-14 4 AS $5.01 $491 D/D (98) 83,680 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-02-15 4 AS $5.00 $495 D/D (99) 83,581 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-02-15 4 AS $5.00 $14,835 D/D (2,967) 2,528,839 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-02-15 4 AS $5.00 $45,740 D/D (9,148) 7,799,423 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-02-15 4 AS $5.00 $255 D/D (51) 43,154 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-02-19 4 AS $5.02 $1,677 D/D (334) 83,247 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-02-19 4 AS $5.02 $50,582 D/D (10,076) 2,518,763 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-02-19 4 AS $5.02 $155,997 D/D (31,075) 7,768,348 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-02-19 4 AS $5.02 $858 D/D (171) 42,983 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-02-20 4 AS $5.01 $30,862 D/D (6,160) 7,762,188 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-02-20 4 AS $5.01 $170 D/D (34) 42,949 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-02-20 4 AS $5.01 $10,010 D/D (1,998) 2,516,765 0 -
  282  Records found
  1   2   3   4  5   6   7   8   9   10   11   12      
  Page 4 of 12  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us